Concentrations |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations | Note 7 – Concentrations
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of its cash and accounts receivable. The Company maintains its cash balances in bank deposit and money market accounts which, at times, may exceed federally insured limits.
Cash and Cash Equivalents
The Company maintains its cash in accounts at financial institutions, which may, at times, exceed federally insured limits. The Company has not experienced any losses on such accounts and does not feel it is exposed to any significant risk with respect to cash. There were amounts exceeding federally insured limits at December 31, 2025, and 2024 of $21,862,085 and $2,196183, respectively.
In addition, the Company held $3,050,000 in restricted cash at December 31, 2025, which is included from federally insured limit calculations and represent amounts held in escrow with construction project review and other contractual obligations.
Sales and Accounts Receivable
During the year ended December 31, 2025 one(1) franchise totaled 26% of sales, and two (2) customers totaled 18 % and 47% accounts receivable.
During the years ended December 31, 2024 one (1) franchise totaled 41% of sales, and one (1) customer totaled 63% accounts receivable.
The Company performs ongoing credit valuations of its customers and management believes that the financial viability of these customers is sound.
Purchases and Payables
There was no concentration of purchases or payables for the Company for the years ended December 31, 2025, and 2024.
|